ZEUS System vs Zio XT ECG Monitoring System
AI Verdict
Choose ZEUS System if…
Choose ZEUS System if your practice requires a powerful, cloud-based AI analytics engine to process and interpret ECG data from various iRhythm wearable biosensors. This system is ideal for integrating cardiac monitoring insights directly into your existing EHR workflows, providing preliminary reports and aiding in comprehensive arrhythmia management across a patient population.
View ZEUS System →Choose Zio XT ECG Monitoring System if…
Choose Zio XT ECG Monitoring System if you need a complete, patient-friendly wearable solution for continuous cardiac monitoring for up to 14 days. This system is best suited for direct patient application, offering high compliance and comfort with its wire-free, water-resistant design, and providing a comprehensive service from data collection to expert-reviewed arrhythmia diagnosis.
View Zio XT ECG Monitoring System →When choosing between the ZEUS System and the Zio XT ECG Monitoring System, physicians should consider their primary need for cardiac monitoring. Both are iRhythm Technologies products, offering AI-powered, cloud-based continuous ECG monitoring for up to 14 days, with FDA clearance and HIPAA compliance. However, their practical applications differ.
The ZEUS System is best suited for practices seeking a comprehensive AI-powered software platform that integrates with various Zio monitors, including the Zio Watch. Its strength lies in its advanced AI for arrhythmia detection and characterization, particularly for Atrial Fibrillation, and its ability to generate preliminary reports. This system is ideal for physicians who prioritize a robust analytical engine and require flexibility in monitor choice for long-term continuous cardiac monitoring.
Conversely, the Zio XT ECG Monitoring System focuses on a complete, integrated solution centered around its proprietary wearable single-lead Zio biosensor. It emphasizes patient comfort with its wire-free, water-resistant design, leading to high patient compliance. The key practical difference is that Zio XT is a self-contained monitoring service, including the biosensor, AI analysis, and expert review. Physicians who prefer a streamlined, all-in-one service with a proven, patient-friendly wearable for accurate arrhythmia diagnosis would likely find Zio XT to be the more appropriate choice.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Not disclosed | Contact for pricing |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware. | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemTool B (Zio XT) explicitly highlights features that enhance patient comfort and compliance, such as its water-resistant, wire-free design, and a patient-activated button for symptomatic event logging. These features are crucial for the overall usability and data quality of a wearable monitoring system. While Tool A (ZEUS System) focuses on physician-facing software, Tool B integrates this with a superior patient experience.
Clinical Value
Zio XT ECG Monitoring SystemWhile both are FDA-cleared and leverage powerful AI, Zio XT (Tool B) has demonstrated superior clinical value through extensive real-world evidence. Studies like CAMELOT show it has the highest diagnostic yield and fastest time to diagnosis compared to other ambulatory cardiac monitors, with lower retesting rates and acute care utilization. The ZEUS System (Tool A) is the underlying AI, but Zio XT represents the complete, clinically validated service.
Pricing & Value
Zio XT ECG Monitoring SystemTool B (Zio XT) offers specific pricing details for both the UK (u00a3310 per patient) and US Medicare (approximately $229-$260.35), providing a clear understanding of the cost per patient for its service. In contrast, Tool A (ZEUS System) provides no disclosed pricing information, making it impossible to assess its value proposition.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being cloud-based on the AWS EC2 platform, HIPAA compliant, and offering Business Associate Agreements (BAA). Tool A explicitly mentions HL7-based EHR integration, and given that Tool B utilizes the ZEUS platform, it is highly probable that Tool B also supports similar integration capabilities.
Innovation
Zio XT ECG Monitoring SystemWhile both tools leverage advanced AI, Tool B (Zio XT) demonstrates greater innovation by combining its FDA-cleared deep-learned AI algorithm with a highly patient-centric wearable biosensor. Features like its water-resistant, wire-free design and high patient compliance represent significant advancements in making long-term cardiac monitoring more practical and effective for patients.
Support & Docs
TieiRhythm Technologies provides extensive support and documentation that covers both the ZEUS System and Zio XT as part of its comprehensive 'Zio Service.' This includes 24/7 patient and provider support, detailed 'Instructions for Use' documents for both the software and the device, and online resources like FAQs and patient education materials.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System | Zio XT ECG Monitoring System |
|---|---|---|
| Name | ZEUS System | Zio XT ECG Monitoring System |
| Company | iRhythm Technologies | iRhythm Technologies |
| Primary Function | AI-powered software that analyzes ECG data from wearable biosensors for long-term continuous cardiac monitoring, aiding in the detection and characterization of arrhythmias. | Wearable, single-lead ECG biosensor for continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. |
| Monitoring Duration | Up to 14 days continuous ECG monitoring. | Up to 14 days continuous ambulatory cardiac monitoring. |
| EHR Integration | HL7-based EHR integration. | Not specified |
| Patient Experience Features | Support for symptomatic and asymptomatic cardiac events. | Wearable single-lead ECG biosensor, water-resistant design, no external leads or wires, patient-activated button for symptomatic event logging, high patient compliance (up to 99%) and satisfaction. |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.